Liquid Biopsy Market is Expected to Reach $11.3 billion | MarketsandMarkets™ Chicago, May 27, 2024 (GLOBE NEWSWIRE) -- Liquid Biopsy market in terms of revenue was estimated to be worth $6.4 billion in 2024 and is poised to reach $11.3 billion by 2029, growing at a CAGR of...

Liquid Biopsy Market projected to reach USD 15.6 Billion by 2030, growing at a CAGR of 16.5% during the forecast period of 2023-2030 - pronounced by MarketDigits in its recent study. Richmond, Nov. 21, 2023 (GLOBE NEWSWIRE) -- According to a research report "Liquid Biopsy Market”, by Offering (Assay Kits, Instruments, Services), Circulating Biomarkers (Circulating Tumor Cells,...

At a CAGR of 18.1% Liquid Biopsy Market size is Expected to Gain $5.8 billion by 2026 Globally - Exclusive Report by MarketsandMarkets™ Chicago, Nov. 04, 2022 (GLOBE NEWSWIRE) -- According to the new market research report "Liquid Biopsy Market by Product (Assay Kits, Instruments, Service), Circulating Biomarkers (CTC, ctDNA),...

Liquid Biopsy Market Growth Rate of 23.80% by 2026 Global Industry Size, Share, Trends, COVID-19 Analysis and Technology Advancements by QIAGEN, MDxHealth, CareDx, Inc., Immucor, Inc., Menarini Silicon Biosystems, Guardant Health, Myriad Genetics SAN FRANCISCO, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Data Bridge Market Research has added a new report titled Global Liquid Biopsy Market with data Tables for historical and forecast years represented...